331 related articles for article (PubMed ID: 33003520)
1. Recent Advances in Nanomedicine for the Diagnosis and Therapy of Liver Fibrosis.
Bai X; Su G; Zhai S
Nanomaterials (Basel); 2020 Sep; 10(10):. PubMed ID: 33003520
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology in Drug Delivery for Liver Fibrosis.
Gu L; Zhang F; Wu J; Zhuge Y
Front Mol Biosci; 2021; 8():804396. PubMed ID: 35087870
[TBL] [Abstract][Full Text] [Related]
3. The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics.
Eftekhari A; Arjmand A; Asheghvatan A; Švajdlenková H; Šauša O; Abiyev H; Ahmadian E; Smutok O; Khalilov R; Kavetskyy T; Cucchiarini M
Front Chem; 2021; 9():674786. PubMed ID: 34055744
[TBL] [Abstract][Full Text] [Related]
4. Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances.
Kasi PB; Mallela VR; Ambrozkiewicz F; Trailin A; Liška V; Hemminki K
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175627
[TBL] [Abstract][Full Text] [Related]
5. Use of Nanotechnology in Diagnosis and Treatment of Hepatic Fibrosis: A Review.
Taymouri S; Taheri A
Curr Drug Deliv; 2016; 13(5):662-72. PubMed ID: 26343151
[TBL] [Abstract][Full Text] [Related]
6. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
Mehata AK; Vikas ; Viswanadh MK; Muthu MS
Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
[TBL] [Abstract][Full Text] [Related]
7. Engineered Exosomes as Theranostic Platforms for Cancer Treatment.
Yang X; Xie X; Liu S; Ma W; Zheng Z; Wei H; Yu CY
ACS Biomater Sci Eng; 2023 Oct; 9(10):5479-5503. PubMed ID: 37695590
[TBL] [Abstract][Full Text] [Related]
8. Biologics, theranostics, and personalized medicine in drug delivery systems.
Puccetti M; Pariano M; Schoubben A; Giovagnoli S; Ricci M
Pharmacol Res; 2024 Mar; 201():107086. PubMed ID: 38295917
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
10. Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics.
Overchuk M; Zheng G
Biomaterials; 2018 Feb; 156():217-237. PubMed ID: 29207323
[TBL] [Abstract][Full Text] [Related]
11. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
Liu Y; Solomon M; Achilefu S
Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
[TBL] [Abstract][Full Text] [Related]
12. Theranostic nanomedicine.
Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances of Light-Mediated Theranostics.
Ai X; Mu J; Xing B
Theranostics; 2016; 6(13):2439-2457. PubMed ID: 27877246
[TBL] [Abstract][Full Text] [Related]
14. Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.
Patel SK; Janjic JM
Theranostics; 2015; 5(2):150-72. PubMed ID: 25553105
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis affects the targeting properties of drug delivery systems to macrophage subsets in vivo.
Ergen C; Niemietz PM; Heymann F; Baues M; Gremse F; Pola R; van Bloois L; Storm G; Kiessling F; Trautwein C; Luedde T; Lammers T; Tacke F
Biomaterials; 2019 Jun; 206():49-60. PubMed ID: 30925288
[TBL] [Abstract][Full Text] [Related]
16. Recent Progress in the Theranostics Application of Nanomedicine in Lung Cancer.
Mukherjee A; Paul M; Mukherjee S
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035440
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine.
Hapuarachchige S; Artemov D
Front Oncol; 2020; 10():1131. PubMed ID: 32793481
[TBL] [Abstract][Full Text] [Related]
18. Emerging nanotherapeutics for antithrombotic treatment.
Zhao Z; Yang F; Zhang X; Sun J; He Z; Luo C
Biomaterials; 2020 Oct; 255():120200. PubMed ID: 32563945
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine and Early Cancer Diagnosis: Molecular Imaging using Fluorescence Nanoparticles.
Jin KT; Yao JY; Ying XJ; Lin Y; Chen YF
Curr Top Med Chem; 2020; 20(30):2737-2761. PubMed ID: 32962614
[TBL] [Abstract][Full Text] [Related]
20. Recent advancement of nanomedicine-based targeted delivery for cervical cancer treatment.
Yadav R; Das PP; Sharma S; Sengupta S; Kumar D; Sagar R
Med Oncol; 2023 Nov; 40(12):347. PubMed ID: 37930458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
